Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 5/29/2026CDE Launches Pilot Program to Accelerate Development of Innovative Rar...
  • 5/29/2026CDE Releases Draft Guideline on Clinical Trial Design for Adolescent W...
  • 5/29/2026CDE Seeks Comments on Draft Guideline for Use of Patient-Reported Outc...
  • 5/29/2026CDE Seeks Public Comments on Draft Bioequivalence Guideline for Iron S...
  • 5/28/2026China Accelerates Approval of Home-Grown Innovative Drugs Amid Biotech...
  • 5/27/2026China Seeks Industry Feedback on eCTD v4.0 Drug Submission Guidelines
  • 5/27/2026China Seeks Feedback on Draft Guidance for Extracellular Vesicle Drug ...
  • 5/25/2026China Issues New Compliance Guidelines for Online Prescription Drug Re...
  • 5/20/2026China Tightens Standards for Generic Drug CMC and Bioequivalence Studi...
  • 5/20/2026CDE Issues M13A Implementation Guidance and First Low-Risk Formulation...
  • 5/20/2026China Adopts ICH M13A Bioequivalence Guideline for Oral Immediate-Rele...
  • 5/15/2026CDE Issues New TCM Post-Approval Change Review Guidelines
  • 5/15/2026CDE Issues Revised Review Guideline for Biologics Change Applications
  • 5/15/2026CDE Releases Revised Review Guideline for Chemical Drug Change Applica...
  • 5/15/2026CDE Releases Operational Procedures for Drug Trial Data Protection Sys...
  • 5/15/2026CDE Issues Filing Requirements for Drug Data Protection Applications
  • 5/15/2026China Introduces Drug Trial Data Protection Rules to Strengthen Pharma...
  • 5/14/2026Singapore and China Sign MoU to Strengthen Cooperation on Health Produ...
  • 5/14/2026China Launches Sweeping Crackdown on Pharmaceutical Kickbacks and Sale...
  • 5/13/20262025 Annual Drug Evaluation Report: Chinese Applications and Reviews H...
  • 5/12/2026Singapore, China Expand Regulatory Partnership to Include Gene and Cel...
  • 5/11/2026CDE Releases Draft MSC Stem Cell Product Guideline for Public Consulta...
  • 5/11/2026NMPA Releases 105th Batch of Generic Drug Reference Formulations
  • 5/11/2026NHC Seeks Comments on Revised Human Genetic Resources Regulation Imple...
  • 5/8/2026CDE Issues Revised Technical Guideline for Recombinant Insulin Product...
  • 5/8/2026China Reports 3.05M ADRs in 2025, Flags Oncology and Anti-Infective Ri...
  • 5/8/2026China Unveils Tougher Nationwide Rules Governing Medical Representativ...
  • 5/6/2026NHC Seeks Public Feedback on Updated Rules for Managing Narcotic and P...
  • 5/6/2026China Formalizes Approval Framework for Clinical Use of Biomedical New...
  • 5/6/2026NHC Releases Trial Rules for Approving Clinical Use of Biomedical New ...
  • Page:1/9 Total number of articles:257: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group